Christopher D. Verrico, Ph.D. - Publications

Affiliations: 
Psychiatry Baylor College of Medicine, Houston, TX 
Area:
Addiction Neuroscience

38 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2019 Verrico CD, Mathai DS, Gu H, Sampson AR, Lewis DA. Recovery from impaired working memory performance during chronic Δ-9-tetrahydrocannabinol administration to adolescent rhesus monkeys. Journal of Psychopharmacology (Oxford, England). 269881119882857. PMID 31621487 DOI: 10.1177/0269881119882857  1
2019 Holst M, Mathai DS, Patel MM, Rodgman C, Keller J, Hussain MZ, De La Garza R, Kosten TR, Verrico CD. Use of Guanfacine for Cannabis use Disorder and Related Symptomology. The American Journal On Addictions. PMID 31483544 DOI: 10.1111/ajad.12959  1
2018 Patel MM, Nielsen DA, Kosten TR, De La Garza R, Newton TF, Verrico CD. FAAH variant Pro129Thr modulates subjective effects produced by cocaine administration. The American Journal On Addictions. PMID 30126012 DOI: 10.1111/ajad.12788  1
2018 Deng H, Verrico CD, Kosten TR, Nielsen DA. Psychosis and synthetic cannabinoids. Psychiatry Research. 268: 400-412. PMID 30125871 DOI: 10.1016/j.psychres.2018.08.012  1
2017 Mathai DS, Holst M, Rodgman C, Haile CN, Keller J, Hussain MZ, Kosten TR, Newton TF, Verrico CD. Guanfacine Attenuates Adverse Effects of Dronabinol (THC) on Working Memory in Adolescent-Onset Heavy Cannabis Users: A Pilot Study. The Journal of Neuropsychiatry and Clinical Neurosciences. appineuropsych161203. PMID 28641496 DOI: 10.1176/appi.neuropsych.16120328  1
2016 Mathai DS, Verrico CD, Shorter D, Coverdale JH, Kosten TR. "Just one bad high:" considering synthetic cannabinoid outcome expectancies in adolescents. The American Journal On Addictions. PMID 27749024 DOI: 10.1111/ajad.12457  1
2016 Rodgman C, Verrico CD, Holst M, Thompson-Lake D, Haile CN, De La Garza R, Raskind MA, Newton TF. Doxazosin XL reduces symptoms of posttraumatic stress disorder in veterans with PTSD: a pilot clinical trial. The Journal of Clinical Psychiatry. 77: e561-e565. PMID 27249080 DOI: 10.4088/JCP.14m09681  1
2016 Verrico CD, Haile CN, De La Garza R, Grasing K, Kosten TR, Newton TF. Subjective and Cardiovascular Effects of Intravenous Methamphetamine during Perindopril Maintenance: A Randomized, Double-Blind, Placebo-Controlled Human Laboratory Study. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). PMID 27207905 DOI: 10.1093/ijnp/pyw029  1
2015 De La Garza R, Verrico CD, Newton TF, Mahoney JJ, Thompson-Lake DG. Safety and Preliminary Efficacy of the Acetylcholinesterase Inhibitor Huperzine A as a Treatment for Cocaine Use Disorder. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). PMID 26364275 DOI: 10.1093/ijnp/pyv098  1
2015 Newton TF, Haile CN, Mahoney JJ, Shah R, Verrico CD, De La Garza R, Kosten TR. Dopamine D3 receptor-preferring agonist enhances the subjective effects of cocaine in humans. Psychiatry Research. 230: 44-9. PMID 26239766 DOI: 10.1016/j.psychres.2015.07.073  1
2015 Mahoney JJ, Thompson-Lake DG, Cooper K, Verrico CD, Newton TF, De La Garza R. A comparison of impulsivity, depressive symptoms, lifetime stress and sensation seeking in healthy controls versus participants with cocaine or methamphetamine use disorders. Journal of Psychopharmacology (Oxford, England). 29: 50-6. PMID 25424624 DOI: 10.1177/0269881114560182  1
2014 Rodgman CJ, Verrico CD, Worthy RB, Lewis EE. Inpatient detoxification from a synthetic cannabinoid and control of postdetoxification cravings with naltrexone. The Primary Care Companion For Cns Disorders. 16. PMID 25664202 DOI: 10.4088/PCC.13l01594  1
2014 Mahoney JJ, De La Garza R, Jackson BJ, Verrico CD, Ho A, Iqbal T, Newton TF. The relationship between sleep and drug use characteristics in participants with cocaine or methamphetamine use disorders. Psychiatry Research. 219: 367-71. PMID 24951161 DOI: 10.1016/j.psychres.2014.05.026  1
2014 Kalechstein AD, Mahoney JJ, Verrico CD, De La Garza R. Short-term, low-dose varenicline administration enhances information processing speed in methamphetamine-dependent users. Neuropharmacology. 85: 493-8. PMID 24930359 DOI: 10.1016/j.neuropharm.2014.05.045  1
2014 Verrico CD, Haile CN, Mahoney JJ, Thompson-Lake DG, Newton TF, De La Garza R. Treatment with modafinil and escitalopram, alone and in combination, on cocaine-induced effects: a randomized, double blind, placebo-controlled human laboratory study. Drug and Alcohol Dependence. 141: 72-8. PMID 24928479 DOI: 10.1016/j.drugalcdep.2014.05.008  1
2014 Verrico CD, Gu H, Peterson ML, Sampson AR, Lewis DA. Repeated Δ9-tetrahydrocannabinol exposure in adolescent monkeys: persistent effects selective for spatial working memory. The American Journal of Psychiatry. 171: 416-25. PMID 24577206 DOI: 10.1176/appi.ajp.2013.13030335  1
2014 Verrico CD, Mahoney JJ, Thompson-Lake DG, Bennett RS, Newton TF, De La Garza R. Safety and efficacy of varenicline to reduce positive subjective effects produced by methamphetamine in methamphetamine-dependent volunteers. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 17: 223-33. PMID 24393456 DOI: 10.1017/S146114571300134X  1
2014 Mahoney JJ, Kalechstein AD, Verrico CD, Arnoudse NM, Shapiro BA, De La Garza R. Preliminary findings of the effects of rivastigmine, an acetylcholinesterase inhibitor, on working memory in cocaine-dependent volunteers. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 50: 137-42. PMID 24239594 DOI: 10.1016/j.pnpbp.2013.11.001  1
2014 Newton TF, Haile CN, Mahoney JJ, Shah R, Verrico CD, De La Garza R, Kosten TR. Dopamine D3 receptor-preferring agonist enhances the subjective effects of cocaine in humans Psychiatry Research. DOI: 10.1016/j.psychres.2015.07.073  1
2013 Verrico CD, Haile CN, Newton TF, Kosten TR, De La Garza R, De La Garza R. Pharmacotherapeutics for substance-use disorders: a focus on dopaminergic medications. Expert Opinion On Investigational Drugs. 22: 1549-68. PMID 24033127 DOI: 10.1517/13543784.2013.836488  1
2013 Volk DW, Siegel BI, Verrico CD, Lewis DA. Endocannabinoid metabolism in the prefrontal cortex in schizophrenia. Schizophrenia Research. 147: 53-7. PMID 23561296 DOI: 10.1016/j.schres.2013.02.038  1
2012 Verrico CD, Liu S, Bitler EJ, Gu H, Sampson AR, Bradberry CW, Lewis DA. Delay- and dose-dependent effects of Δ⁹-tetrahydrocannabinol administration on spatial and object working memory tasks in adolescent rhesus monkeys. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 37: 1357-66. PMID 22218091 DOI: 10.1038/npp.2011.321  1
2011 Verrico CD, Liu S, Asafu-Adjei JK, Sampson AR, Bradberry CW, Lewis DA. Acquisition and baseline performance of working memory tasks by adolescent rhesus monkeys. Brain Research. 1378: 91-104. PMID 21215729 DOI: 10.1016/j.brainres.2010.12.081  1
2010 Eggan SM, Stoyak SR, Verrico CD, Lewis DA. Cannabinoid CB1 receptor immunoreactivity in the prefrontal cortex: Comparison of schizophrenia and major depressive disorder. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 35: 2060-71. PMID 20555313 DOI: 10.1038/npp.2010.75  1
2008 Verrico CD, Lynch L, Fahey MA, Fryer AK, Miller GM, Madras BK. MDMA-induced impairment in primates: antagonism by a selective norepinephrine or serotonin, but not by a dopamine/norepinephrine transport inhibitor. Journal of Psychopharmacology (Oxford, England). 22: 187-202. PMID 18308800 DOI: 10.1177/0269881107083639  1
2007 Verrico CD, Miller GM, Madras BK. MDMA (Ecstasy) and human dopamine, norepinephrine, and serotonin transporters: implications for MDMA-induced neurotoxicity and treatment. Psychopharmacology. 189: 489-503. PMID 16220332 DOI: 10.1007/s00213-005-0174-5  1
2005 Miller GM, Verrico CD, Jassen A, Konar M, Yang H, Panas H, Bahn M, Johnson R, Madras BK. Primate trace amine receptor 1 modulation by the dopamine transporter. The Journal of Pharmacology and Experimental Therapeutics. 313: 983-94. PMID 15764732 DOI: 10.1124/jpet.105.084459  1
2004 Verrico CD, Jentsch JD, Roth RH, Taylor JR. Repeated, intermittent delta(9)-tetrahydrocannabinol administration to rats impairs acquisition and performance of a test of visuospatial divided attention. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 29: 522-9. PMID 14694348 DOI: 10.1038/sj.npp.1300316  1
2003 Verrico CD, Jentsch JD, Roth RH. Persistent and anatomically selective reduction in prefrontal cortical dopamine metabolism after repeated, intermittent cannabinoid administration to rats. Synapse (New York, N.Y.). 49: 61-6. PMID 12710016 DOI: 10.1002/syn.10215  1
2003 Verrico CD, Jentsch JD, Dazzi L, Roth RH. Systemic, but not local, administration of cannabinoid CB1 receptor agonists modulate prefrontal cortical acetylcholine efflux in the rat. Synapse (New York, N.Y.). 48: 178-83. PMID 12687636 DOI: 10.1002/syn.10202  1
2002 De La Garza R, Jentsch JD, Verrico CD, Roth RH. Adaptation of monoaminergic responses to phencyclidine in nucleus accumbens and prefrontal cortex following repeated treatment with fluoxetine or imipramine. Brain Research. 958: 20-7. PMID 12468026 DOI: 10.1016/S0006-8993(02)03772-1  1
2001 George TP, Picciotto MR, Verrico CD, Roth RH. Effects of nicotine pretreatment on dopaminergic and behavioral responses to conditioned fear stress in rats: dissociation of biochemical and behavioral effects. Biological Psychiatry. 49: 300-6. PMID 11230881 DOI: 10.1016/S0006-3223(00)00928-8  1
2000 George TP, Verrico CD, Picciotto MR, Roth RH. Nicotinic modulation of mesoprefrontal dopamine neurons: pharmacologic and neuroanatomic characterization. The Journal of Pharmacology and Experimental Therapeutics. 295: 58-66. PMID 10991961  1
2000 George TP, Verrico CD, Xu L, Roth RH. Effects of repeated nicotine administration and footshock stress on rat mesoprefrontal dopamine systems: Evidence for opioid mechanisms. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 23: 79-88. PMID 10869888 DOI: 10.1016/S0893-133X(99)00165-7  1
1998 Jentsch JD, Dazzi L, Chhatwal JP, Verrico CD, Roth RH. Reduced prefrontal cortical dopamine, but not acetylcholine, release in vivo after repeated, intermittent phencyclidine administration to rats. Neuroscience Letters. 258: 175-8. PMID 9885959 DOI: 10.1016/S0304-3940(98)00879-9  1
1998 Jentsch JD, Verrico CD, Le D, Roth RH. Repeated exposure to delta 9-tetrahydrocannabinol reduces prefrontal cortical dopamine metabolism in the rat. Neuroscience Letters. 246: 169-72. PMID 9792619 DOI: 10.1016/S0304-3940(98)00254-7  1
1998 George TP, Verrico CD, Roth RH. Effects of repeated nicotine pre-treatment on mesoprefrontal dopaminergic and behavioral responses to acute footshock stress. Brain Research. 801: 36-49. PMID 9729261 DOI: 10.1016/S0006-8993(98)00537-X  1
1996 Fernstrom MH, Verrico CD, Ebaugh AL, Fernstrom JD. Diet-induced changes in serum cholesterol concentrations do not alter tryptophan hydroxylation rate or serotonin concentrations in gerbil brain. Life Sciences. 58: 1433-44. PMID 8622569 DOI: 10.1016/0024-3205(96)00113-0  1
Show low-probability matches.